Sof marja: Prime Medicine Bio (PRME)

Prime Medicine Corp (PRME) tovar belgisi

Prime Medicine, Inc. (PRME) o'zining prime tahrirlash tizimini patentlash orqali noyob R&D ustunligini yaratmoqda. Maqsadli sof marja ushbu salohiyatni ko'rsatadi, bunda ko'rsatkich hozirda -2497.60 darajasida turibdi. Biznesning o'sishi tartibga soluvchi organlarning tasdiqlari va terapiyalarning kengayishiga bog'liq. Shu bilan birga, laboratoriyalarning diversifikatsiyasi xomashyo xavfsizligini va murakkab genetik dori vositalarini tashishda logistik ishonchlilikni ta'minlaydi.

primemedicine.com (PRME) - Sof marja 28.04.2023dan 20.11.2026gacha

Prime Medicine Bio (PRME) boʻyicha maʼlumotlarning jamlanma tahliliy kesimlari

- aksiya kursi va ekspertlarning narx prognozi:
- kompaniyaning birjadagi kapitallashuv ko'rsatkichlari:
Kompaniyaning jamlanma tahlili:Prime Medicine Inc - PRME
Prime Medicine Corp yetakchi tovari

Prime Medicine, Inc. (PRME) yuqori aniqlikdagi genom tahrirlash sohasining yetakchisi sifatida tadqiqot va ishlanmalarga ( R&D ) ulkan resurslarni investitsiya qilmoqda, bu esa uning moliyaviy natijalariga bevosita ta'sir ko'rsatmoqda. Joriy sof foyda marjasini tahlil qilish barcha xarajatlardan keyin har bir dollar daromaddan olingan haqiqiy foydani baholash imkonini beradi, bu esa investorlarga operatsion samaradorlikni ob'ektiv o'lchashga va aksiyalarni haddan tashqari qimmatga sotib olishdan qochishga yordam beradi.

Asosiy raqobatchilar

TEM: Sotuvning sof marjinal rentabelligi|Sof foyda bo'yicha marjinallik Qiagen QGEN|IONS (Isis Pharmaceuticals) - Sotuvning sof marjinal rentabelligi|Repligen Inc. - Sof foyda marjasi|Sotuvning sof marjinal rentabelligi RNA|CRSP - Sof marja|GeneDx - Sof foyda bo'yicha sotuv rentabelligi|Sof foyda normasi RARE|Beam Tx - Sotuvning sof marjinal rentabelligi|SRPT - Sotuvning sof marjinal rentabelligi|TWST (Twist Bio) - Sof foyda bo'yicha sotuv rentabelligi|Sotuvning sof rentabelligi TXG|Sof foyda bo'yicha sotuv rentabelligi NTLA|Stoke Therapeutics Inc (STOK) - Kompaniya sotuv marjasi|Sotuvning sof marjinal rentabelligi BLFS|Sof marja WVE (Wave Life Sciences Corp)|Sof marja Maze Therapeutics MAZE|Sof foyda normasi SION|TSHA - Sof marja|QURE (uniQure) - Sotuvning sof rentabelligi|MeiraGTx Corp (MGTX) - Sof marja|Regenxbio - Sof foyda normasi|Sof marja solidbio.com|Sof marja ocugen.com OCGN|Sotuvning sof marjinal rentabelligi PACB|Benitec - Sotuvning sof rentabelligi|Sof marja Design Therapeutics DSGN|Sotuvning sof marjinal rentabelligi Rocket Pharmaceuticals RCKT|Sof foyda marjasi 4D Molecular Corp|LXEO: Sof marja|KRRO (Korro Bio, Inc) - Sof foyda bo'yicha sotuv rentabelligi|Editas Medicine (EDIT) - Sotuvning sof marjinal rentabelligi|Sof marja Silence Therapeutics Inc.|Sotuvning sof rentabelligi PRQR (proqr.com)|Sof marja Codexis Bio (CDXS)|Sotuvning sof marjinal rentabelligi sangamo.com (SGMO)|Sof marja nautilus.bio NAUT|Kompaniya sotuv marjasi Metagenomi, Inc (MGX)|Precision BioSciences Inc. - Sotuvning sof marjinal rentabelligi|GBIO - Sotuvning sof marjinal rentabelligi|BOLD: Sotuvning sof marjinal rentabelligi|Sotuvning sof rentabelligi XCUR|Sof marja Imunon|Phio Pharmaceuticals - Sof foyda marjasi|Sof marja Mustang Bio, Inc. (MBIO)|Kompaniya sotuv marjasi TransCode Therapeutics, Inc.|Sof marja Bionano Genomics BNGO|Sof foyda normasi APDN|BLUE - Sof marja|Sof foyda marjasi IPA|Omega Therapeutics, Inc. (OMGA) - Sof marja|Singular Genomics Corp (OMIC) - Sotuvning sof marjinal rentabelligi|RGLS (Regulus Therapeutics, Inc.) - Sotuvning sof marjinal rentabelligi|SYRS: Sof foyda normasi|Sof foyda bo'yicha sotuv rentabelligi TBIO (Telesis Bio Inc.)|Sotuvning sof marjinal rentabelligi TRACON Pharmaceuticals Inc. (TCON)|Sof marja Unity Bio UBX